A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)

  1. Forster, M.
  2. Hackshaw, A.
  3. De Pas, T.
  4. Cobo, M.
  5. Garrido, P.
  6. Summers, Y.
  7. Dingemans, A.-M.C.
  8. Flynn, M.
  9. Schnell, D.
  10. von Wangenheim, U.
  11. Loembé, A.-B.
  12. Kaiser, R.
  13. Lee, S.M.
Aldizkaria:
Lung Cancer

ISSN: 1872-8332,  0169-5002

Argitalpen urtea: 2018

Alea: 120

Orrialdeak: 27-33

Mota: Artikulua

DOI: 10.1016/J.LUNGCAN.2018.03.007 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus